Vitiligo Treatment Options: Creams, Phototherapy & Depigmentation Explained

Vitiligo treatment has advanced significantly in recent years, with new options including JAK inhibitors joining established treatments like topical steroids, phototherapy, and monobenzone depigmentation therapy. This guide explains all current options — what they are, who they work for, and how to choose.

Understanding Vitiligo

Vitiligo is an autoimmune condition where the immune system attacks and destroys melanocytes — the skin cells responsible for producing melanin (pigment). The result is white patches that can appear anywhere on the body. Vitiligo affects approximately 1-2% of the global population, with higher rates in the Middle East and South Asia.

There is no cure for vitiligo — meaning treatments do not repair the underlying immune mechanism. Instead, they either attempt to restore pigmentation to affected areas (repigmentation) or remove remaining pigmentation to create uniform skin tone (depigmentation).

Repigmentation vs Depigmentation

Topical Treatments (Repigmentation)

Topical Corticosteroids

The first-line treatment for limited vitiligo. Work by suppressing the autoimmune attack on melanocytes. Effective particularly for newly active vitiligo on the face and trunk. Long-term use on the face carries risk of skin atrophy and telangiectasia.

Topical Calcineurin Inhibitors (Tacrolimus, Pimecrolimus)

Non-steroidal alternatives approved for eczema and widely used off-label for vitiligo, particularly on the face. Lower risk of skin thinning than steroids. Effective for facial vitiligo in many patients.

Topical JAK Inhibitors (Ruxolitinib — Opzelura)

FDA-approved in 2022 for non-segmental vitiligo in adults and adolescents. Ruxolitinib cream has shown significantly better repigmentation rates than previous topical options. Expensive and requires prescription.

Phototherapy Options

Narrowband UVB (NB-UVB)

The most widely used phototherapy for vitiligo. Delivered 2-3 times per week in a dermatology clinic or at home with a handheld device. Best results on the face and trunk. Requires 6-12+ months of treatment. Risk of photoageing with long-term use.

PUVA (Psoralen + UVA)

Older phototherapy modality — less commonly used now due to carcinogenicity risk with long-term use. Still used in some specialist centres.

Excimer Laser

Targeted UVB laser for limited vitiligo patches. Good results on resistant areas but expensive and clinic-dependent.

JAK Inhibitors — The New Standard?

Baricitinib and ruxolitinib (oral and topical JAK inhibitors) have shown the most significant repigmentation results of any vitiligo treatment to date. Ruxolitinib cream (Opzelura) is FDA-approved. Oral baricitinib is widely used off-label. These represent the most significant advance in vitiligo treatment in decades.

Limitations: Expensive; require prescription; not available in all countries; long-term safety still being assessed; effect may not be permanent if treatment is stopped.

Depigmentation Therapy with Monobenzone

When repigmentation has failed or is impractical for extensive vitiligo, depigmentation therapy with monobenzone cream offers a path to a uniform skin appearance. By permanently removing remaining pigmented skin, monobenzone creates consistency between vitiligo patches and surrounding skin.

Monobenzone 20% cream (Monozan® by Behvazan Pharmaceutical Co.) is available from GulfDermaCare with delivery to all GCC countries in 3-7 days. See our complete guide: Complete Guide to Depigmentation Therapy.

Choosing the Right Treatment

Frequently Asked Questions